World’s Only Approved Total Artificial Heart Surpasses 500 Implants in the U.S.
Author Archive: AZBio
Seena Magowitz Foundation donates $500,000 for TGen pancreatic cancer research
Major charity golf tournaments in Phoenix and Atlanta help fund successful clinical trials of drug that helps extend patients’ livesContinue reading
UA Spin-Off to Test Cancer-Preventing Drug Combination
From treating cancer to preventing cancer – this is the vision of Tucson-based company Cancer Prevention Pharmaceuticals, co-founded by former UA professor Eugene Gerner.Continue reading
Phase III Colon Cancer Prevention Therapy Trial Now Open for Enrollment
Cancer Prevention Pharmaceuticals, Inc., (CPP) announced today the launch of a Phase III colon cancer prevention trial in collaboration with the National Cancer Institute (NCI) and SWOG, an NCI-supported clinical trials group. The Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) trial is a Phase III trial testing CPP’s prevention therapy product CPP-1X/sul (eflornithine/sulindac) in 1340 colon cancer survivors—each of whom will receive daily treatment for three years to prevent the recurrence of cancer or high-risk polyps.Continue reading
Congressman Ron Barber of Arizona Champions Innovation and Challenges the Medical Device Excise Tax
Rep. Barber Speaks about Tax Reform and Growing Small Businesses.
Congressman Barber’s questions focused on how specific taxes can create roadblocks for medical device manufacturers using SynCardia Systems, Inc. and the Medical Device excise tax as a great example of how our tax code can stifle creativity and innovation . Continue reading
TGen-led study discovers dramatic changes in bacteria following male circumcision
Study examines changes in the penis microbiomeContinue reading
Virtual Clinic Showcases New Technology for Teaching Medical Students
The state-of-the-art center at the UA College of Medicine-Phoenix allows students to develop diagnostic skills and patient care abilitiesContinue reading
UA Robotics Surgery Brings Hope to Patients with Mesothelioma
UA Performs World’s First and Second Robot-Assisted Surgeries for MesotheliomaContinue reading
Opportunity Alert: Grants for pilot DNA-seq and RNA-seq research projects
The Biodesign Institute at ASU’s Personalized Diagnostics Genomics Core together with Illumina invite you to apply for a grant program that offers an opportunity for innovative investigators to pilot DNA-seq and RNA-seq research projects using the Illumina HiSeq2000 DNA sequencer. Continue reading